Bristol-Myers Squibb (BMY) Offers Low Volatility and High Yield

Bristol-Myers Squibb Company (BMY) ranks 5th among the best defensive stocks and is recognized for low volatility and high yield. The stock features a beta that is approximately 73% less volatile than the S&P 500. Recent updates include a quarterly dividend of $0.63 per share and a cash payout ratio of about 35%. In the recent quarter, growth products like Camzyos and Sotyktu saw a 10% increase, which strengthens BMY's long-term revenue outlook despite some earnings challenges.